Welcome to the CRL Insurer Services blog! Here you will find commentary from our dedicated team of medical directors and industry leaders on lab research and trends, innovative services and solutions, and what’s new at CRL. Click the button below to get the latest news directly to your inbox. Questions? Contact us at ILSsales@crlcorp.com.
Dr. Michael Fulks, Consulting Medical Director, discusses recent articles on several new obesity drugs that are hoped to be cheaper… Read More
Tags: Diabetes, Life Insurance, Mortality, Obesity, Weight loss
Dr. Michael Fulks, Consulting Medical Director, discusses current research on triglyceride levels and their impact on cardiovascular mortality risk. Way… Read More
Tags: Cholesterol, Life Insurance, Mortality, Triglycerides, Underwriting
Dr. Steven Rigatti, Consulting Medical Director to CRL, comments on a study showing how death rates caused by falls have… Read More
Tags: Deaths by falls, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks, Consulting Medical Director, highlights a report discussing the prevalence and recommendation for annual screening of heart failure… Read More
Tags: Diabetes, Heart failure, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks, Consulting Medical Director, details a new study showcasing the increase in mortality rates from drug and alcohol… Read More
Tags: Alcohol usage, Drug usage, Life expectancy, Life Insurance, Mortality, Overdose
Michael Fulks, MD, comments on recent research in the Journal of the American College of Cardiology. Dr. Fulks reviews the… Read More
Tags: Coronary heart disease, HDL, Life Insurance, Mortality, Research
In conjunction with industry partners APPS, ExamOne, and IMS Paramed, we recently collaborated on an effort to analyze and understand… Read More
Tags: Diabetes, Hypertension, Life Insurance, Mortality, Underwriting
Dr. Michael Fulks comments on drugs targeted for weight loss in patients with type 2 diabetes. Last year we blogged… Read More
Tags: Life Insurance, Metabolism, Mortality, Weight loss
Consulting Medical Director Michael Fulks discusses new data from the CDC for evaluating drug use, potential overdose risk, and life… Read More
Tags: Drug usage, Life Insurance, Mortality, Overdose
Mortality has steadily improved in the U.S. until recently, when COVID-19 and fentanyl-related deaths increased. However, the disparity in mortality… Read More
Tags: Life expectancy, Life Insurance, Mortality